Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Oncotarget|April 24, 2016
Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathwayXiumin Wang, Yingying Wang, Gang Xiao, et al.Cancer Metastasis Reviews|September 15, 2010
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progressionXueqing Sun, Guangcun Cheng, Mingang Hao, et al.Scientific Reports|October 21, 2025
SATU-net: a shadow adaptive tracing U-net for gastric cavity segmentation based on the principle of ultrasound imagingHankun Zhang, Tie Zhou, Siqi Wang, et al.Oncotarget|April 25, 2015
CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanismsGang Xiao, Xiumin Wang, Jinglong Wang, et al.BMC Cancer|December 5, 2019
Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancerXueqing Sun, Qing Qu, Yimin Lao, et al.Materials (Basel, Switzerland)|March 24, 2019
Cationic Albumin Encapsulated DNA Origami for Enhanced Cellular Transfection and StabilityXuemei Xu, Shiqi Fang, Yuan Zhuang, et al.The Journal of Biological Chemistry|June 12, 2023
Mitochondrial folate metabolism-mediated α-linolenic acid exhaustion masks liver fibrosis resolutionYanjie Gao, Bingfeng Zheng, Shuaiqi Xu, et al.Carcinogenesis|January 29, 2016
The feedback loop between miR-124 and TGF-β pathway plays a significant role in non-small cell lung cancer metastasisLidong Zu, Yunjing Xue, Jinglong Wang, et al.Molecular Cancer Research : MCR|July 2, 2013
Dual inhibition of PI3K and mTOR mitigates compensatory AKT activation and improves tamoxifen response in breast cancerXiaosong Chen, Meizhong Zhao, Mingang Hao, et al.Cancer Research|December 4, 2013
HIC1 silencing in triple-negative breast cancer drives progression through misregulation of LCN2Guangcun Cheng, Xueqing Sun, Jinglong Wang, et al.Pageof 6